Skip to main content
Erschienen in: European Radiology 2/2019

27.07.2018 | Chest

Prognostic value of radiomic analysis of iodine overlay maps from dual-energy computed tomography in patients with resectable lung cancer

verfasst von: Jooae Choe, Sang Min Lee, Kyung-Hyun Do, Jung Bok Lee, Sang Min Lee, June-Goo Lee, Joon Beom Seo

Erschienen in: European Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate whether radiomics on iodine overlay maps from dual-energy computed tomography (DECT) can predict survival outcomes in patients with resectable lung cancer.

Methods

Ninety-three lung cancer patients eligible for curative surgery were examined with DECT at the time of diagnosis. The median follow-up was 60.4 months. Radiomic features of the entire primary tumour were extracted from iodine overlay maps generated by DECT. A Cox proportional hazards regression model was used to determine independent predictors of overall survival (OS) and disease-free survival (DFS), respectively.

Results

Forty-two patients (45.2%) had disease recurrence and 39 patients (41.9%) died during the follow-up period. The mean DFS was 49.8 months and OS was 55.2 months. Univariate analysis revealed that significant predictors of both OS and DFS were stage and radiomic parameters, including histogram energy, histogram entropy, grey-level co-occurrence matrix (GLCM) angular second moment, GLCM entropy and homogeneity. The multivariate analysis identified stage and entropy as independent risk factors predicting both OS (stage, hazard ratio (HR) = 2.020 [95% CI 1.014–4.026], p = 0.046; entropy, HR = 1.543 [95% CI 1.069–2.228], p = 0.021) and DFS (stage, HR = 2.132 [95% CI 1.060–4.287], p = 0.034; entropy, HR = 1.497 [95% CI 1.031–2.173], p = 0.034). The C-index showed that adding entropy improved prediction of OS compared to stage only (0.720 and 0.667, respectively; p = 0.048).

Conclusions

Radiomic features extracted from iodine overlay map reflecting heterogeneity of tumour perfusion can add prognostic information for patients with resectable lung cancer.

Key Points

• Radiomic feature (histogram entropy) from DECT iodine overlay maps was an independent risk factor predicting both overall survival and disease-free survival.
• Adding histogram entropy to clinical stage improved prediction of overall survival compared to stage only (0.720 and 0.667, respectively; p = 0.048).
• DECT can be a good option for comprehensive pre-operative evaluation in cases of resectable lung cancer.
Literatur
1.
2.
Zurück zum Zitat Mitsudomi T, Suda K, Yatabe Y (2013) Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol 10:235–244CrossRefPubMed Mitsudomi T, Suda K, Yatabe Y (2013) Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol 10:235–244CrossRefPubMed
3.
Zurück zum Zitat al-Kattan K, Sepsas E, Fountain SW, Townsend ER (1997) Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12:380–384CrossRefPubMed al-Kattan K, Sepsas E, Fountain SW, Townsend ER (1997) Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12:380–384CrossRefPubMed
4.
Zurück zum Zitat Uramoto H, Nakanishi R, Nagashima A et al (2010) A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. Anticancer Res 30:4695–4699PubMed Uramoto H, Nakanishi R, Nagashima A et al (2010) A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. Anticancer Res 30:4695–4699PubMed
5.
Zurück zum Zitat Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892CrossRefPubMedPubMedCentral Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Nitadori J-i, Bograd AJ, Kadota K et al (2013) Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or Smaller. J Natl Cancer Inst 105:1212–1220CrossRefPubMedPubMedCentral Nitadori J-i, Bograd AJ, Kadota K et al (2013) Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or Smaller. J Natl Cancer Inst 105:1212–1220CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Patnaik SK, Kannisto E, Knudsen S, Yendamuri S (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70:36–45CrossRefPubMed Patnaik SK, Kannisto E, Knudsen S, Yendamuri S (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70:36–45CrossRefPubMed
8.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMed Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMed
9.
Zurück zum Zitat Straume O, Chappuis PO, Salvesen HB et al (2002) Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res 62:6808–6811PubMed Straume O, Chappuis PO, Salvesen HB et al (2002) Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res 62:6808–6811PubMed
10.
Zurück zum Zitat Maeda R, Ishii G, Ito M et al (2012) Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol 7:503–511CrossRefPubMed Maeda R, Ishii G, Ito M et al (2012) Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol 7:503–511CrossRefPubMed
11.
Zurück zum Zitat Zhao YY, Xue C, Jiang W et al (2012) Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab. J Thorac Oncol 7:71–75CrossRefPubMed Zhao YY, Xue C, Jiang W et al (2012) Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab. J Thorac Oncol 7:71–75CrossRefPubMed
12.
Zurück zum Zitat Son JY, Lee HY, Kim JH et al (2016) Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping. Eur Radiol 26:43–54CrossRefPubMed Son JY, Lee HY, Kim JH et al (2016) Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping. Eur Radiol 26:43–54CrossRefPubMed
13.
Zurück zum Zitat Kim YN, Lee HY, Lee KS et al (2012) Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response? Korean J Radiol 13:702–710CrossRefPubMedPubMedCentral Kim YN, Lee HY, Lee KS et al (2012) Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response? Korean J Radiol 13:702–710CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bae JM, Jeong JY, Lee HY et al (2017) Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images. Oncotarget 8:523–535PubMed Bae JM, Jeong JY, Lee HY et al (2017) Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images. Oncotarget 8:523–535PubMed
15.
Zurück zum Zitat Sobin LH, Gospodarowicz MKCW (2009) UICC International Union Against Cancer. TNM Classification of Malignant Tumours. Lung and pleural tumours. Wiley-Blackwell, Oxford England, pp 138–146 Sobin LH, Gospodarowicz MKCW (2009) UICC International Union Against Cancer. TNM Classification of Malignant Tumours. Lung and pleural tumours. Wiley-Blackwell, Oxford England, pp 138–146
16.
Zurück zum Zitat Chae EJ, Song J-W, Seo JB, Krauss B, Jang YM, Song K-S (2008) Clinical Utility of Dual-Energy CT in the Evaluation of Solitary Pulmonary Nodules: Initial Experience. Radiology 249:671–681CrossRefPubMed Chae EJ, Song J-W, Seo JB, Krauss B, Jang YM, Song K-S (2008) Clinical Utility of Dual-Energy CT in the Evaluation of Solitary Pulmonary Nodules: Initial Experience. Radiology 249:671–681CrossRefPubMed
17.
Zurück zum Zitat Chae EJ, Kim N, Seo JB et al (2013) Prediction of Postoperative Lung Function in Patients Undergoing Lung Resection: Dual-Energy Perfusion Computed Tomography Versus Perfusion Scintigraphy. Investigative Radiology 48:622–627CrossRefPubMed Chae EJ, Kim N, Seo JB et al (2013) Prediction of Postoperative Lung Function in Patients Undergoing Lung Resection: Dual-Energy Perfusion Computed Tomography Versus Perfusion Scintigraphy. Investigative Radiology 48:622–627CrossRefPubMed
18.
Zurück zum Zitat Wu K, Garnier C, Coatrieux J-L, Shu H (2010) A preliminary study of moment-based texture analysis for medical images. Conf Proc IEEE Eng Med Biol Soc 2010:5581–5584PubMedCentral Wu K, Garnier C, Coatrieux J-L, Shu H (2010) A preliminary study of moment-based texture analysis for medical images. Conf Proc IEEE Eng Med Biol Soc 2010:5581–5584PubMedCentral
19.
Zurück zum Zitat Soh L., C. T (1999) Texture analysis of SAR sea ice imagery using gray level co-occurrence matrices. IEEE Trans Geosci Remote Sens 37:780–795 Soh L., C. T (1999) Texture analysis of SAR sea ice imagery using gray level co-occurrence matrices. IEEE Trans Geosci Remote Sens 37:780–795
20.
Zurück zum Zitat Eo S, Kang HJ, Hong S, Cho HJ (2014) K-Adaptive Partitioning for Survival Data, with an Application to Cancer Staging Eo S, Kang HJ, Hong S, Cho HJ (2014) K-Adaptive Partitioning for Survival Data, with an Application to Cancer Staging
21.
Zurück zum Zitat Portney LG, M.P. W (2000) Foundations of clinical research: applications to practice, 3rd edn. Prentice Hall, New Jersey Portney LG, M.P. W (2000) Foundations of clinical research: applications to practice, 3rd edn. Prentice Hall, New Jersey
22.
Zurück zum Zitat Yoon SH, Park CM, Park SJ, Yoon JH, Hahn S, Goo JM (2016) Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging. Radiology 280:940–948CrossRefPubMed Yoon SH, Park CM, Park SJ, Yoon JH, Hahn S, Goo JM (2016) Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging. Radiology 280:940–948CrossRefPubMed
23.
Zurück zum Zitat Hayano K, Kulkarni NM, Duda DG, Heist RS, Sahani DV (2016) Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. AJR Am J Roentgenol 206:987–993CrossRefPubMed Hayano K, Kulkarni NM, Duda DG, Heist RS, Sahani DV (2016) Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. AJR Am J Roentgenol 206:987–993CrossRefPubMed
24.
Zurück zum Zitat Huang Y, Liu Z, He L et al (2016) Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer. Radiology 281:947–957CrossRefPubMed Huang Y, Liu Z, He L et al (2016) Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer. Radiology 281:947–957CrossRefPubMed
25.
Zurück zum Zitat Johnson TR, Krauss B, Sedlmair M et al (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517CrossRefPubMed Johnson TR, Krauss B, Sedlmair M et al (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517CrossRefPubMed
26.
Zurück zum Zitat Swinson DE, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ (2002) Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer 37:235–240CrossRefPubMed Swinson DE, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ (2002) Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer 37:235–240CrossRefPubMed
27.
Zurück zum Zitat Park SY, Lee HS, Jang HJ, Lee GK, Chung KY, Zo JI (2011) Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg 91:1668–1673CrossRefPubMed Park SY, Lee HS, Jang HJ, Lee GK, Chung KY, Zo JI (2011) Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg 91:1668–1673CrossRefPubMed
28.
Zurück zum Zitat Kilicgun A, Turna A, Sayar A, Solak O, Urer N, Gurses A (2010) Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion. Thorac Cardiovasc Surg 58:93–97CrossRefPubMed Kilicgun A, Turna A, Sayar A, Solak O, Urer N, Gurses A (2010) Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion. Thorac Cardiovasc Surg 58:93–97CrossRefPubMed
29.
Zurück zum Zitat Kang M-J, Park CM, Lee C-H, Goo JM, Lee HJ (2010) Dual-Energy CT: Clinical Applications in Various Pulmonary Diseases. Radiographics 30:685–698CrossRefPubMed Kang M-J, Park CM, Lee C-H, Goo JM, Lee HJ (2010) Dual-Energy CT: Clinical Applications in Various Pulmonary Diseases. Radiographics 30:685–698CrossRefPubMed
30.
Zurück zum Zitat Parmar C, Rios Velazquez E, Leijenaar R et al (2014) Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One 9:e102107CrossRefPubMedPubMedCentral Parmar C, Rios Velazquez E, Leijenaar R et al (2014) Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One 9:e102107CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Liu J, Dong M, Sun X, Li W, Xing L, Yu J (2016) Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One 11:e0146195CrossRefPubMedPubMedCentral Liu J, Dong M, Sun X, Li W, Xing L, Yu J (2016) Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One 11:e0146195CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Satoh Y, Onishi H, Nambu A, Araki T (2014) Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology 270:275–281CrossRefPubMed Satoh Y, Onishi H, Nambu A, Araki T (2014) Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology 270:275–281CrossRefPubMed
34.
Zurück zum Zitat Kumar V, Nath K, Berman CG et al (2013) Variance of Standardised Uptake Values for FDG-PET/CT Greater in Clinical Practice than Under Ideal Study Settings. Clin Nucl Med 38:175–182CrossRefPubMedPubMedCentral Kumar V, Nath K, Berman CG et al (2013) Variance of Standardised Uptake Values for FDG-PET/CT Greater in Clinical Practice than Under Ideal Study Settings. Clin Nucl Med 38:175–182CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Nahmias C, Wahl LM (2008) Reproducibility of standardised uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med 49:1804–1808CrossRefPubMed Nahmias C, Wahl LM (2008) Reproducibility of standardised uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med 49:1804–1808CrossRefPubMed
Metadaten
Titel
Prognostic value of radiomic analysis of iodine overlay maps from dual-energy computed tomography in patients with resectable lung cancer
verfasst von
Jooae Choe
Sang Min Lee
Kyung-Hyun Do
Jung Bok Lee
Sang Min Lee
June-Goo Lee
Joon Beom Seo
Publikationsdatum
27.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5639-0

Weitere Artikel der Ausgabe 2/2019

European Radiology 2/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.